Concepedia

Publication | Open Access

Vascular Effects of Improving Metabolic Control With Metformin or Rosiglitazone in Type 2 Diabetes

DOIFull Paper Access

180

Citations

43

References

2004

Year

Andrea Natali, Stephanie E Baldeweg, Elena Toschi, Brunella Capaldo, Daniele Barbaro, Amalia Gastaldelli, John Yudkin, Ele Ferrannini
Diabetes Care

Abstract

At equivalent glycemic control, rosiglitazone, but not metformin, improves endothelium dependent vasodilatation and insulin sensitivity in type 2 diabetes.

References

YearCitations

Page 1